Uberti-Foppa Caterina Professore associatoMedicineMED/17 – Malattie infettive




Caterina Uberti-Foppa, MD, born in Pianengo (Cremona), graduated at the University of Milan in 1983, and specialized  with Summa Cum Laude in Infectious and Tropical Diseases at the University of Milan in 1987. At the San Raffaele Scientific Institute (Milan, Italy) she is Deputy Director at Division of Infectious Diseases since 1991. She is also  Professor in Infectious Diseases at University “Vita Salute San Raffaele”  of Milan for Master of Science in Medicine and  for the School of Specialization in Infectious Diseases since 2000.

She has a vast  experience in infectious diseases  and hepatotropic viruses. She  is Group Leader  of   the “Unit for Study and Therapy of Diseases from  Hepatotropic Viruses”, a clinical research unit carried out at the Department of Infectious Diseases.

The unit collaborates with national and international networks (PITER, EuroSIDA, EUROSUPPORT, ICONA, COHERE, Regional Network for  HCV therapy) and receives funding from pharmaceutical companies for  the conduction of national and international  phase II-IV  treatment studies  and  from national ( ICONA) and international (EuroSIDA, EUROSUPPORT) agencies.

Her area of interest in mainly focused  on the study and treatment of hepatotropic viral infections and of new treatment strategy for HIV positive subjects. Her research interest is  mainly focused on  the distribution of HCV natural resistance in Hepatitis C genotypes  and  on the role of gene variants  as predictors of severe liver steatosis and/or  liver fibrosis in HIV/HCV coinfected subjects.  In addition , her research interests include the diagnostic accuracy of non-invasive biomarkers of fibrosis for the diagnosis of liver cirrhosis and the pharmacokinetics of antiretroviral drugs in combination with anti-HCV therapies  in HIV/HCV positive patients with cirrhosis. She is a member of Italian Infectious Diseases Society and of International AIDS Society. Prof. Caterina Uberti-Foppa is also consultant in Infectious Diseases in  the Scientific Institutes in Milan (C.Besta Neurologic Institute, National Institute of Oncology).

Caterina Uberti Foppa is author of  101 original articles published in peer-reviewed journals (PubMed), h-index (January 2017): 15 (Source Scopus). She is  also  author of 12 chapters in books about Infectious Diseases for the degree course in Medicine and the Specialization in Infectious Diseases.


101- Merli M, Galli L, Marinaro L, Ariaudo A, Messina E, Uberti-Foppa C, Castagna A, D’Avolio A, Lazzarin A, Bonora S, Hasson H. Pharmacokinetics of dolutegravir and rilpivirine in combination with simeprevir and sofosbuvir in HIV/hepatitis C virus-coinfected patients with liver cirrhosis. J Antimicrob Chemother. 2016 Dec 20. pii: dkw492. doi: 10.1093/jac/dkw492.


100- Sagnelli C, Merli M, Uberti-Foppa C, Hasson H, Grandone A, Cirillo G, Salpietro S, Minichini C, Starace M, Messina E, Morelli P, Miraglia Del Giudice E, Lazzarin A, Coppola N, Sagnelli E. TM6SF2 E167K variant predicts severe liver fibrosis for human immunodeficiency/hepatitis C virus co-infected patients, and severe steatosis only for a non-3 hepatitis C virus genotype.World J Gastroenterol. 2016 Oct 14;22(38):8509-8518.


99- Merli M, Castagna A, Salpietro S, Gianotti N, Messina E, Poli A, Morsica G, Bagaglio S, Cernuschi M, Bigoloni A, Uberti-Foppa C, Lazzarin A, Hasson H Diagnostic accuracy of APRI, FIB-4 and Forns for the detection of liver cirrhosis in HIV/HCV-coinfected patients.  New Microbiol. 2016 Feb;39(2):110-3. PMID:27196548.  IF (2015/2016) 1.784 ; ISSN: 1121-7138

98-Bagaglio S, Andolina A, Merli M, Uberti-Foppa C, Morsica G. Frequency of Natural Resistance within NS5a Replication Complex Domain in Hepatitis C Genotypes 1a, 1b: Possible Implication of Subtype-Specific Resistance Selection in Multiple Direct Acting Antivirals Drugs Combination Treatment.Viruses. 2016 Mar 25;8(4). pii: E91. doi: 10.3390/v8040091.PMID:27023593. IF (2015/2016) 3.353 ; ISSN: 1999-4915

97- Sagnelli C, Merli M, Uberti-Foppa C, Hasson H, Cirillo G, Grandone A, Salpietro S,

Minichini C, Del Giudice EM, Lazzarin A, Sagnelli E, Coppola N. Impact of PNPLA3 variants on

the liver histology of 168 patients with HIV infection and chronic hepatitis C. Clin Microbiol Infect.

2016 Jan 19. pii:S1198-743X(16)00007-0. doi: 10.1016/j.cmi.2015.11.025. [Epub ahead of print]

PubMed PMID: 26806136. IF (2015/2016) 4.575; ISSN:  1198-743X (Print), 1469-0691 (Electronic)


96- Cattaneo D, Puoti M, Sollima S, Moioli C, Foppa CU, Baldelli S, Clementi E, Gervasoni C.J

Reduced raltegravir clearance in HIV-infected liver transplant recipients: an unexpected interaction

with immunosuppressive therapy? Antimicrob Chemother. 2016 Jan 10. pii: dkv466. [Epub ahead

of prin t] PMID: 26755497  . IF (2015/2016) 4.476; ISSN: 0066-4804 (Print), 1098-6596 (Online)


95- Merli M, Messina E, Salpietro S, Lazzarin A, Uberti-Foppa C, Hasson H. Marked

Decrease in Lymphocyte Count in HIV/Hepatitis C Virus (HCV)-Coinfected Patients

With Advanced Liver Disease During Anti-HCV Treatment With Direct-Acting

Antiviral Regimens Including Ribavirin. Clin Infect Dis. 2016 Feb 15;62(4):527-8.

doi: 10.1093/cid/civ902. Epub 2015 Oct 27. PubMed PMID: 26508514. IF (2015/2016) 8.736; ISSN: 1058-4838 (Print), 1537-6591 (Electronic)


94- Bagaglio S, Uberti-Foppa C, Di Serio C, Trentini F, Andolina A, Hasson H,

Messina E, Merli M, Porrino L, Lazzarin A, Morsica G. Dynamic of Mixed HCV

Infection in Plasma and PBMC of HIV/HCV Patients Under Treatment With

Peg-IFN/Ribavirin. Medicine (Baltimore). 2015 Oct;94(43):e1876. doi:

10.1097/MD.0000000000001876. PubMed PMID: 26512601.  IF (2015/2016) 5.723; ISSN: 0025-7974


93- Bagaglio S, Uberti-Foppa C, Messina E, Merli M, Hasson H, Andolina A, Galli A,

Lazzarin A, Morsica G. Distribution of natural resistance to NS3 protease

inhibitors in hepatitis C genotype 1a separated into clades 1 and 2 and in

genotype 1b of HIV-infected patients. Clin Microbiol Infect. 2015 Dec 17. pii:

S1198-743X(15)01033-2. doi: 10.1016/j.cmi.2015.12.007. [Epub ahead of print]

PubMed PMID: 26706617.  IF (2015/2016) 4.575; ISSN:  1198-743X (Print), 1469-0691 (Electronic)


92- Hasson H, Messina E, Merli M, Della Torre L, Morsica G, Bagaglio S, Lazzarin

A, Uberti-Foppa C. Sustained virological response after ten days of triple

anti-hepatitis C virus (HCV) therapy with telaprevir plus pegylated interferon

and ribavirin in an HIV/HCV co-infected cirrhotic woman. Int J Infect Dis. 2014

Dec;29:100-2. doi: 10.1016/j.ijid.2014.08.011. Epub 2014 Oct 24. PubMed PMID:

  1. IF (2014) 1.859; ISSN: 1201-9712


91-  Armignacco O, Andreoni M, Sagnelli E, Puoti M, Bruno R, Gaeta GB, Perno CF,

Santantonio TA, Bonfanti P, Bonora S, Borderi M, Castagna A, d’Arminio Monforte

A, De Luca A, Grossi P, Guaraldi G, Maggiolo F, Mussini C, Sagnelli C, Tavio M,

Torti C, Uberti-Foppa C, Andreoni M, Angarano G, Antinori A, Armignacco O, Carosi

G, Chirianni A, Di Perri G, Galli M, Lazzarin A, Rizzardini G, Sagnelli E,

Taliani G. Recommendations for the use of hepatitis C virus protease inhibitors

for the treatment of chronic hepatitis C in HIV-infected persons. A position

paper of the Italian Association for the Study of Infectious and Tropical

Disease. New Microbiol. 2014 Oct;37(4):423-38. Epub 2014 Oct 1. PubMed PMID:

  1. IF (2014) 1.784 ; ISSN: 1121-7138

90- Cogliati M, Zamfirova RR, Tortorano AM, Viviani MA; Fimua Cryptococcosis Network.Molecular epidemiology of Italian clinical Cryptococcus neoformans var. grubii isolates.Med Mycol. 2013 Jul;51(5):499-506. doi: 10.3109/13693786.2012.751642. Epub 2013 Jan 4.PMID: 23286351.   IF (2013) 2.261 ; ISSN: ISSN: 1369-3786 (Print), 1460-2709 (Online)

89- Sagnelli C, Uberti-Foppa C, Galli L, Pasquale G, Coppola N, Albarello L,Doglioni C, Lazzarin A, Sagnelli E. Anti-hepatitis C virus treatment may prevent the progression of liver fibrosis in non-responder human immunodeficiency virus/hepatitis C virus coinfected patients. Braz J Infect Dis. 2014 Mar-Apr;18(2):164-9. doi: 10.1016/j.bjid.2013.06.005. Epub 2013 Oct 25. PubMed PMID: 24650995. IF (2013) 1.299;  ISSN: 1413-8670

88- Platteau T, Müller MC, Nideröst S, Csepe P, Dedes N, Apers L, Schrooten W,

Nöstlinger C; Eurosupport 5 Study Group. Patients’ satisfaction with sexual and

reproductive health services delivered in HIV clinics across European regions.

Cent Eur J Public Health. 2013 Sep;21(3):123-7.;PubMed PMID: 24344532.  IF (2013) 0.798; ISSN: 1210-7778


87- Sagnelli C, Uberti-Foppa C, Pasquale G, De Pascalis S, Coppola N, Albarello L,

Doglioni C, Lazzarin A, Sagnelli E. Factors influencing liver fibrosis and

necroinflammation in HIV/HCV coinfection and HCV monoinfection. Infection. 2013

Oct;41(5):959-67. doi: 10.1007/s15010-013-0502-3. Epub 2013 Jul 10. PubMed PMID:

  1. IF (2013) 2.864; ISSN: 0300-8126 (Print), 1439-0973 (Online)


86- Hasson H, Merli M, Galli L, Gallotta G, Carbone A, Messina E, Bagaglio S,

Morsica G, Salpietro S, Castagna A, Lazzarin A, Uberti-Foppa C. Non-invasive

fibrosis biomarkers – APRI and Forns – are associated with liver stiffness in

HIV-monoinfected patients receiving antiretroviral drugs. Liver Int. 2013

Aug;33(7):1113-20. doi: 10.1111/liv.12159. Epub 2013 Mar 28. PubMed PMID:

23534616  . IF (2013) 4.412; ISSN: 1478-3223 (Print), 1478-3231 (Electronic)


85-  Brombin C, Diomede L, Tudor D, Drillet AS, Pastori C, Poli E, Riva A,

Uberti-Foppa C, Galli M, Di Serio C, Bomsel M, Lopalco L. A nonparametric

procedure for defining a new humoral immunologic profile in a pilot study on HIV

infected patients. PLoS One. 2013;8(3):e58768. doi: 10.1371/journal.pone.0058768.

Epub 2013 Mar 22. PubMed PMID: 23533590; PubMed Central PMCID: PMC3606389. IF (2013) 3.534; ISSN: 1932-6203.


84- Bagaglio S, Messina E, Uberti-Foppa C, Merli M, Torre LD, Lazzarin A, Hasson

H, Morsica G. Reversion of naturally occurring high-level resistance mutations to

NS3 protease inhibitors in two treatment-naive individuals infected with

hepatitis C virus. J Antimicrob Chemother. 2013 Jun;68(6):1448-50. doi:

10.1093/jac/dkt019. Epub 2013 Feb 6. PubMed PMID: 23390206. IF (2013) 5.439; ISSN: 0305-7453 (Print), 1460-2091 (Electronic)

83- Nöstlinger C, Desjardins F, Dec J, Platteau T, Hasker E; Eurosupport V Study Group. Child desire in women and men living with HIV attending HIV outpatient clinics: evidence from a European multicentre study. Eur J Contracept Reprod Health Care. 2013 Aug;18(4):251-63. doi: 10.3109/13625187.2013.801072. Epub 2013 Jun 5. PMID: 2373888. IF (2013) 1,835;  ISSN: 1362-5187 (Print), 1473-0782 (Online)

82- Hasson H, Galli L, Gallotta G, Neri V, Blanc P, D’Annunzio M, Morsica G,

Sollima S, Merli M, Lazzarin A, Uberti-Foppa C. HAART simplification with

lopinavir/ritonavir monotherapy in HIV/HCV co-infected patients starting anti-HCV

treatment: a randomised pilot study (KaMon study). New Microbiol. 2012.

Oct;35(4):469-74. Epub 2012 Oct 1. PubMed PMID: 23109014.   IF (2012) 1.667 ; ISSN: 1121-7138


81- Schiavini M, Angeli E, Mainini A, Uberti-Foppa C, Zerbi P, Sagnelli C,

Cargnel A, Vago G, Duca PG, Giorgi R, Rizzardini G, Gubertini G. Fibrosis

progression in paired liver biopsies from HIV/HCV co-infected patients. Hepat

Mon. 2011 Jul 1;11(7):525-31. PubMed PMID: 22706343; PubMed Central PMCID:

PMC3212761.  IF (2011) 2.19 ;  ISSN: 1735-143X (Print), 1735-3408 (Online)


80- Miro JM, Manzardo C, Mussini C, Johnson M, d’Arminio Monforte A, Antinori A,

Gill MJ, Sighinolfi L, Uberti-Foppa C, Borghi V, Sabin C; Late Presenters

Investigators. Survival outcomes and effect of early vs. deferred cART among

HIV-infected patients diagnosed at the time of an AIDS-defining event: a cohort

analysis. PLoS One. 2011;6(10):e26009. doi: 10.1371/journal.pone.0026009. Epub

2011 Oct 17. PubMed PMID: 22043301; PubMed Central PMCID: PMC3197144. IF (2011) 4.092; ISSN: 1932-6203.

79- Nideröst S, Gredig D, Roulin C, Rickenbach M; Swiss Hiv Cohort Study; Eurosupport 5 Study Group. Predictors of HIV-protection behaviour in HIV-positive men who have sex with casual male partners: a test of the explanatory power of an extended Information-Motivation-Behavioural Skills model. AIDS Care. 2011 Jul;23(7):908-19. doi: 10.1080/09540121.2010.538661. IF (2011) 0.  ISSN: 0954-0121

78- Nöstlinger C, Nideröst S, Platteau T, Müller MC, Staneková D, Gredig D,

Roulin C, Rickenbach M, Colebunders R; Swiss HIV Cohort Study and The Eurosupport

Study Group. Sexual protection behavior in HIV-positive gay men: testing a

modified information-motivation-behavioral skills model. Arch Sex Behav. 2011

Aug;40(4):817-27. doi: 10.1007/s10508-010-9682-4. Epub 2010 Sep 28. PubMed PMID:

  1. IF (2011) 0; ISSN: 0004-0002


77-  Sagnelli C, Uberti-Foppa C, Galli L, Pasquale G, Coppola N, Albarello L,

Masiello A, Doglioni C, Lazzarin A, Sagnelli E. Liver histology in HIV/hepatitis

C-coinfected and HCV-monoinfected patients with persistently normal alanine

aminotransferases. J Acquir Immune Defic Syndr. 2010 May 1;54(1):107-8. doi:

10.1097/QAI.0b013e3181cf4d8b. Erratum in: J Acquir Immune Defic Syndr. 2010 Jul

1;54(3):338. Galli, Laura [added]. PubMed PMID: 20418725. IF (2010) 3.39; ISSN: 1525-4135 (Print), 1944-7884 (Electronic)


76- Morsica G, Bianchi G, Bagaglio S, Conte C, Salpietro S, Porrino L, Uberti-Foppa C. Hepatic safety profile of darunavir with low-dose ritonavir (DRV/r) in HIV/HCV coinfected and HIV monoinfected patients.New Microbiol. 2011 Jul;34(3):317-21. Epub 2011 Jul 30. PMID:21811753.  IF (2011) 1 ; ISSN: 1121-7138

75- Bagaglio S, Bianchi G, Danise A, Porrino L, Uberti-Foppa C, Lazzarin A, Castagna A, Morsica G.Longitudinal evaluation of occult hepatitis B infection in HIV-1 infected individuals during highly active antiretroviral treatment interruption and after HAART resumption. Infection. 2011 Apr;39(2):121-6. doi: 10.1007/s15010-011-0093-9. Epub 2011 Mar 22. PMID:21424854. IF (2011) 2.659; ISSN: 0300-8126 (Print), 1439-0973 (Online)

74- Nöstlinger C, Nideröst S, Gredig D, Platteau T, Gordillo V, Roulin C, Rickenbach M, Dias SF, Rojas D; Swiss HIV Cohort Study; Eurosupport5 Study Group. Condom use with steady partners among heterosexual people living with HIV in Europe: testing the information-motivation-behavioral skills model. AIDS Patient Care STDS. 2010 Dec;24(12):771-80. doi: 10.1089/apc.2010.0246. Epub 2010 Nov 22.  IF (2010) 2.333;  ISSN: 1087-2914

73- Bagaglio S, Albarello L, Biswas P, Uberti-Foppa C, Fortis C, Morsica G. Virological pattern of hepatitis B infection in an HIV-positive man with fatal fulminant hepatitis B: a case report. J Med Case Rep. 2009 Nov 9;3:110. doi:10.1186/1752-1947-3-110. PubMed PMID: 19946588; PubMed Central PMCID: PMC2783051. IF 2009 0,  ISSN: 1752-1947.


72- Angeli E, Mainini A, Cargnel A, Uberti-Foppa C, Orani A, Carbone R, Andreoni

M, Schiavini M, Giorgi R, Rizzardini G, Gubertini G; ICoS-2 Group. Predictability

of sustained virological response to pegylated interferon alpha-2b Plus ribavirin

therapy by week-8 viral response in HIV-positive patients with chronic hepatitis

C virus infection. Curr HIV Res. 2009 Jul;7(4):447-55. PubMed PMID: 19601782.  IF (2009) 1.978;   ISSN: 1570-162X (Print), 1873-4251 (Online)


71- Morsica G, Bagaglio S, Cicconi P, Capobianchi MR, Pellizzer G, Caramello P,

Orani A, Moioli C, Rizzardini G, Uberti-Foppa C, Puoti M, Monforte AD; Hepa

I.C.o.N.A the Icona Foundation Study Groups. Viral interference between hepatitis

B, C, and D viruses in dual and triple infections in HIV-positive patients. J

Acquir Immune Defic Syndr. 2009 Aug 15;51(5):574-81. doi: 10.1097/QAI.0b013e3181add592. PubMed PMID: 19590432.IF (2009) 4.207; ISSN: 1525-4135 (Print), 1944-7884 (Electronic)


70- Gordillo V, Fekete E, Platteau T, Antoni MH, Schneiderman N, Nöstlinger C;

Eurosupport Study Group. Emotional support and gender in people living with HIV:

effects on psychological well-being. J Behav Med. 2009 Dec;32(6):523-31. doi:

10.1007/s10865-009-9222-7. PubMed PMID: 19543823. .IF (2009)  0; ISSN: 0160-7715


69- Morsica G, Bagaglio S, Uberti-Foppa C, Galli L, Lazzarin A. Detection of

hepatitis C mutants with natural resistance to NS3/4A protease inhibitors in

HIV/HCV-coinfected individuals treated with antiretroviral therapy. J Acquir

Immune Defic Syndr. 2009 May 1;51(1):106-8. doi: 10.1097/QAI.0b013e3181a02fda.

PubMed PMID: 19390331. IF (2009) 4.207; ISSN: 1525-4135 (Print), 1944-7884 (Electronic)


68- Hirbod T, Kaldensjö T, Lopalco L, Klareskog E, Andersson S, Uberti-Foppa C,

Ferrari D, Manghi M, Andersson J, Loré K, Broliden K. Abundant and superficial

expression of C-type lectin receptors in ectocervix of women at risk of HIV

infection. J Acquir Immune Defic Syndr. 2009 Jul 1;51(3):239-47. doi:

10.1097/QAI.0b013e3181a74f89. PubMed PMID: 19363450. IF (2009) 4.207; ISSN: 1525-4135 (Print), 1944-7884 (Electronic)


67- Mussini C, Manzardo C, Johnson M, Monforte Ad, Uberti-Foppa C, Antinori A,

Gill MJ, Sighinolfi L, Borghi V, Lazzarin A, Miró JM, Sabin C; Late Presenter

Investigators. Patients presenting with AIDS in the HAART era: a collaborative

cohort analysis. AIDS. 2008 Nov 30;22(18):2461-9. doi:

10.1097/QAD.0b013e328314b5f1. PubMed PMID: 19005269. IF (2008) 5.46; ISSN: 0269-9370 (Print), 1473-5571 (Electronic)


66- Valentini LG, Casali C, Chatenoud L, Chiaffarino F, Uberti-Foppa C, Broggi G.

Surgical site infections after elective neurosurgery: a survey of 1747 patients.

Neurosurgery. 2008 Jan;62(1):88-95; discussion 95-6. doi:

10.1227/01.NEU.0000311065.95496.C5. PubMed PMID: 18300895. IF (2008) 3.398; ISSN: 0148-396X (Print), 1524-4040 (Online)


65- Spagnuolo V, Gentilini G, De Bona A, Galli L, Uberti-Foppa C, Soldarini A,

Dorigatti F, Seminari E. Liver function parameters in HIV/HCV co-infected

patients treated with amprenavir and ritonavir and correlation with plasma

levels. New Microbiol. 2007 Jul;30(3):279-82. PubMed PMID: 17802909. IF (2007) 0.956 ; ISSN: 1121-7138


64- De Bona A, Galli L, Gallotta G, Guzzo A, Alagna L, Lazzarin A, Uberti-Foppa

  1. C. Rate of cirrhosis progression reduced in HIV/HCV co-infected non-responders to

anti-HCV therapy. New Microbiol. 2007 Jul;30(3):259-64. PubMed PMID: 17802905.


63- Fluur C, Rethi B, Thang PH, Vivar N, Mowafi F, Lopalco L, Foppa CU, Karlsson A, Tambussi G, Chiodi F. Relationship between serum IL-7 concentrations and lymphopenia upon different levels of HIV immune control. AIDS. 2007 May 11;21(8):1048-50. PMID: 17457102 IF (2007) 5.842; ISSN: 0269-9370 (Print), 1473-5571 (Electronic)


62- Seminari E, De Bona A, Gentilini G, Galli L, Schira G, Gianotti N,

Uberti-Foppa C, Soldarini A, Dorigatti F, Lazzarin A, Castagna A. Amprenavir and

ritonavir plasma concentrations in HIV-infected patients treated with

fosamprenavir/ritonavir with various degrees of liver impairment. J Antimicrob

Chemother. 2007 Oct;60(4):831-6. Epub 2007 Aug 7. PubMed PMID: 17684056.  IF (2007) 4.038; ISSN: 0305-7453 (Print), 1460-2091 (Electronic)


61- Hirbod T, Nilsson J, Andersson S, Uberti-Foppa C, Ferrari D, Manghi M,

Andersson J, Lopalco L, Broliden K. Upregulation of interferon-alpha and RANTES

in the cervix of HIV-1-seronegative women with high-risk behavior. J Acquir

Immune Defic Syndr. 2006 Oct 1;43(2):137-43. PubMed PMID: 16940859. IF (2006) 3.806; ISSN: 1525-4135 (Print), 1944-7884 (Electronic)


60- Sitia G, De Bona A, Bagaglio S, Galli L, Paties CT, Uberti-Foppa C, Guidotti

LG, Lazzarin A, Morsica G. Naive HIV/HCV-coinfected patients have higher

intrahepatic pro-inflammatory cytokines than coinfected patients treated with

antiretroviral therapy. Antivir Ther. 2006;11(3):385-9. PubMed PMID: 16759056. IF (2006) 4.892; ISSN: 1359-6535 (Print), 2040-2058 (Electronic)


59- Lillo FB, Uberti-Foppa C. Human papillomavirus viral load: a possible marker

for cervical disease in HIV-infected women. J Antimicrob Chemother. 2006

May;57(5):810-4. Epub 2006 Mar 23. PubMed PMID: 16556637.  IF (2006) 3.891; ISSN: 0305-7453 (Print), 1460-2091 (Electronic)


58- Pastori C, Weiser B, Barassi C, Uberti-Foppa C, Ghezzi S, Longhi R, Calori G,

Burger H, Kemal K, Poli G, Lazzarin A, Lopalco L. Long-lasting CCR5

internalization by antibodies in a subset of long-term nonprogressors: a possible

protective effect against disease progression. Blood. 2006 Jun

15;107(12):4825-33. Epub 2006 Mar 7. PubMed PMID: 16522810; PubMed Central PMCID:

PMC1895813. IF (2006) 10.370; ISSN: 0006-4971 (Print), 1528-0020 (Electronic)


57- Uberti-Foppa C, De Bona A, Galli L, Sitia G, Gallotta G, Sagnelli C, Paties

C, Lazzarin A. Liver fibrosis in HIV-positive patients with hepatitis C virus:

role of persistently normal alanine aminotransferase levels. J Acquir Immune

Defic Syndr. 2006 Jan 1;41(1):63-7. PubMed PMID: 16340475. IF (2006) 3.946; ISSN: 1525-4135 (Print), 1944-7884 (Electronic)



56- Lillo FB, Lodini S, Ferrari D, Stayton C, Taccagni G, Galli L, Lazzarin A,

Uberti-Foppa C. Determination of human papillomavirus (HPV) load and type in

high-grade cervical lesions surgically resected from HIV-infected women during

follow-up of HPV infection. Clin Infect Dis. 2005 Feb 1;40(3):451-7. Epub 2005

Jan 7. PubMed PMID: 15668870. IF (2005) 6.510; ISSN: 1058-4838 (Print), 1537-6591 (Electronic)


55-  Bossolasco S, Gaiera G, Olchini D, Gulletta M, Martello L, Bestetti A, Bossi

L, Germagnoli L, Lazzarin A, Uberti-Foppa C, Cinque P. Real-time PCR assay for

clinical management of human immunodeficiency virus-infected patients with

visceral leishmaniasis. J Clin Microbiol. 2003 Nov;41(11):5080-4. Erratum in: J

Clin Microbiol. 2004 Apr;42(4):1858. PubMed PMID: 14605142; PubMed Central PMCID:

PMC262523. IF (2004) 3.439; ISSN: 0095-1137 (Print), 1098-660X (Electronic)


54-  Bucceri AM, Somigliana E, Matrone R, Uberti-Foppa C, Viganò P, Vignali M.

Discontinuing combination antiretroviral therapy during the first trimester of

pregnancy: insights from plasma human immunodeficiency virus-1 RNA viral load and

CD4 cell count. Am J Obstet Gynecol. 2003 Aug;189(2):545-51. PubMed PMID:

  1. IF (2003) 2.518; ISSN: 0002-9378 (Print), 1097-6868 (Online)


53- De Bona A, Sitia G, Uberti-Foppa C, Galli L, Ciuffreda D, Gallotta G, Paties

C, Lazzarin A. Impact of HAART on liver histology of HIV/HCV coinfected patients.

J Biol Regul Homeost Agents. 2003 Apr-Jun;17(2):195-7. PubMed PMID: 14518723.

  1. IF (2003) 0.748; ISSN: 0393-974X


52- Canducci F, Uberti Foppa C, Boeri E, Racca S, Gallotta G, Grasso MA, Calori

G, Lazzarin A, Clementi M. Characterization of GBV-C infection in HIV-1 infected

patients. J Biol Regul Homeost Agents. 2003 Apr-Jun;17(2):191-4. PubMed PMID:

  1. IF (2003) 0.748; ISSN: 0393-974X


51- Uberti-Foppa C, Ferrari D, Lodini S, Reina S, Ameglio F, Grasso MA, Gallotta

G, Ferrari A, Taccagni G, Lazzarin A, Lillo FB. Long-term effect of highly active

antiretroviral therapy on cervical lesions in HIV-positive women. AIDS. 2003 Sep

26;17(14):2136-8. PubMed PMID: 14502023. IF (2003) 5.521; ISSN: 0269-9370 (Print), 1473-5571 (Electronic)


50- Uberti-Foppa C, De Bona A, Morsica G, Galli L, Gallotta G, Boeri E, Lazzarin

  1. Pretreatment of chronic active hepatitis C in patients coinfected with HIV and

hepatitis C virus reduces the hepatotoxicity associated with subsequent

antiretroviral therapy. J Acquir Immune Defic Syndr. 2003 Jun 1;33(2):146-52.

PubMed PMID: 12794546. IF (2003) 3.681; ISSN: 1525-4135 (Print), 1944-7884 (Electronic)


49- Kirk O, Reiss P, Uberti-Foppa C, Bickel M, Gerstoft J, Pradier C, Wit FW,

Ledergerber B, Lundgren JD, Furrer H; European HIV Cohorts. Safe interruption of

maintenance therapy against previous infection with four common HIV-associated

opportunistic pathogens during potent antiretroviral therapy. Ann Intern Med.

2002 Aug 20;137(4):239-50. PubMed PMID: 12186514. IF (2002) 11.414; ISSN: 0003-4819 (Print), 1539-3704 (Electronic)

48- European Confederation of Medical Mycology (ECMM) prospective survey of cryptococcosis: report from Italy.[No authors listed] Med Mycol. 2002 Oct;40(5):507-17.PMID:12462531. IF (2002) 2.067; ISSN: 1369-3786 (Print), 1460-2709 (Online)

47- Pastori C, Barassi C, Lillo F, Longhi R, Capiluppi B, Nozza S, Galli A,

Uberti-Foppa C, Lazzarin A, Tambussi G, Lopalco L. The effect of HAART on humoral

immune response in primary HIV-1 infected patients. J Biol Regul Homeost Agents.

2002 Jan-Mar;16(1):9-17. PubMed PMID: 12003182. IF (2002) 0.603;  ISSN: 0393-974X


46-  Moretti F, Uberti-Foppa C, Quiros-Roldan E, Fanti L, Lillo F, Lazzarin A.

Oesophagobronchial fistula caused by varicella zoster virus in a patient with

AIDS: a unique case. J Clin Pathol. 2002 May;55(5):397-8. PubMed PMID: 11986352;

PubMed Central PMCID: PMC1769657. IF (2002) 2.549;  ISSN: 0021-9746 (Print), 1472-4146 (Online)


45- Matteucci P, Magni M, Di Nicola M, Carlo-Stella C, Uberti C, Gianni AM Leukoencephalopathy and papovavirus infection after treatment with chemotherapy and anti-CD20 monoclonal antibody. Blood. 2002 Aug 1;100(3):1104-5. No abstract available. PMID: 12150156 IF (2002) 9.631; ISSN: 0006-4971 (Print), 1528-0020 (Electronic)


44- Lillo FB, Ferrari D, Veglia F, Origoni M, Grasso MA, Lodini S, Mastrorilli E,

Taccagni G, Lazzarin A, Uberti-Foppa C. Human papillomavirus infection and

associated cervical disease in human immunodeficiency virus-infected women:

effect of highly active antiretroviral therapy. J Infect Dis. 2001 Sep

1;184(5):547-51. Epub 2001 Aug 9. PubMed PMID: 11494160. IF (2001) 4.910;  ISSN: 0022-1899 (Print), 1537-6613 (Online)

43- Sitia G, Cella D, De Mitri MS, Novati R, Foppa CU, Perackis K, Bianchi C, Lazzarin A, Morsica G Evolution of the E2 region of hepatitis C virus in an infant infected by mother-to-infant transmission. J Med Virol. 2001 Aug;64(4):476-81. PMID: 11468732  IF (2001) 2.881;  ISSN: 0146-6615 (Print), 1096-9071 (Online)

42- Ledergerber B, Mocroft A, Reiss P, Furrer H, Kirk O, Bickel M, Uberti-Foppa

C, Pradier C, D’Arminio Monforte A, Schneider MM, Lundgren JD; Eight European

Study Groups. Discontinuation of secondary prophylaxis against Pneumocystis

carinii pneumonia in patients with HIV infection who have a response to

antiretroviral therapy. Eight European Study Groups. N Engl J Med. 2001 Jan

18;344(3):168-74. PubMed PMID: 11188837. IF (2001) 29.065; ISSN: 0028-4793 (Print), 1533-4406 (Electronic)


41- Gianotti N, Uberti-Foppa C, Boeri E, Marinelli M, Tambussi G, Finazzi R,

Lazzarin A. Hepatitis B surface antigen clearance and appearance of antibodies

against hepatitis B surface antigen after treatment with recombinant interleukin

2 in a human immunodeficiency virus-infected patient. Hepatology. 2000

Dec;32(6):1409-10. PubMed PMID: 11186868. IF (2000) 7.304; ISSN: 0270-9139 (Print), 1527-3350 (Electronic)





40- Morsica G, De Bona A, Foppa CU, Sitia G, Finazzi R, Lazzarin A. Ribavirin therapy for chronic hepatitis C does not modify HIV viral load in HIV-1 positive patients under antiretroviral treatment. AIDS. 2000 Jul 28;14(11):1656-8. No abstract available. PMID: 10983654 IF (2000) 8.018; ISSN: 0269-9370 (Print), 1473-5571 (Electronic)


39- Uberti-Foppa C, De Bona A, Morsica G, Guffanti M, Gianotti N, Boeri E,

Lazzarin A. Recombinant interleukin-2 for treatment of HIV reduces hepatitis C

viral load in coinfected patients. AIDS. 1999 Jan 14;13(1):140-1. PubMed PMID:

  1. IF (1999) 6.931; ISSN: 0269-9370 (Print), 1473-5571 (Electronic)


38- Uberti-Foppa C, Origoni M, Maillard M, Ferrari D, Ciuffreda D, Mastrorilli E,

Lazzarin A, Lillo F. Evaluation of the detection of human papillomavirus

genotypes in cervical specimens by hybrid capture as screening for precancerous

lesions in HIV-positive women. J Med Virol. 1998 Oct;56(2):133-7. PubMed PMID: 9746069. IF (1998) 2.594;  ISSN: 0146-6615 (Print), 1096-9071 (Online)


37- Uberti-Foppa C, Lillo F, Terreni MR, Puglisi A, Guffanti M, Gianotti N,

Lazzarin A. Cytomegalovirus pneumonia in AIDS patients: value of cytomegalovirus

culture from BAL fluid and correlation with lung disease. Chest. 1998

Apr;113(4):919-23. PubMed PMID: 9554626. IF (1998) 2.246; ISSN: 0012-3692 (Print), 1931-3543 (Electronic)


36- Uberti-Foppa C, Finazzi R, De Bona A. Recombinant interferon-alpha therapy

and meno-metrorrhagia. Br J Obstet Gynaecol. 1998 Mar;105(3):367-8. PubMed PMID:

9533004.if (1998) 2.299;  ISSN: 1470-0328 (Print)-1471-0528 (Electronic)


35- Morsica G, Bernardi MT, Novati R, Uberti Foppa C, Castagna A, Lazzarin A.

Detection of hepatitis C virus genomic sequences in the cerebrospinal fluid of

HIV-infected patients. J Med Virol. 1997 Nov;53(3):252-4. PubMed PMID: 9365891. IF (1997) 3.188;  ISSN: 0146-6615 (Print), 1096-9071 (Online)


34- Bettini P, Boeri E, Lillo F, Abecasis C, Farma E, Crociati E, Uberti-Foppa C,

Varnier OE. HIV-1 RNA quantification by one-tube quantitative NASBA in

HIV-infected patients. AIDS. 1996 Dec;10(14):1735-7. PubMed PMID: 8970695. IF (1996) 5.983; ISSN: 0269-9370 (Print), 1473-5571 (Electronic)


33- Uberti-Foppa C, Fumagalli L, Gianotti N, Viviani AM, Vaiani R, Gieho E. First

case of osteomyelitis due to Phialophora richardsiae in a patient with HIV

infection. AIDS. 1995 Aug;9(8):975-6. PubMed PMID: 7576338. IF (1995) 4.878; ISSN: 0269-9370 (Print), 1473-5571 (Electronic)


32- Gianotti N, Finazzi R, Uberti Foppa C, Danise A, Migone T, Lazzarin A. The

thymic hormones in the treatment of immune deficiency related to HIV infection.

Pharmacol Res. 1992 Sep;26 Suppl 2:62-3. PubMed PMID: 1409328.  IF (1992) 0.702; ISSN: 1043-6618 (Print), 1096-1186 (Online)




31- Lazzarin A, Castagna A, Cavalli G, Amprimo MC, Vaj M, Parravicini CL, Costanzi G, Ronchi P, Foppa CU, Moroni M, Turconi R.Cerebrospinal fluid beta 2-microglobulin in AIDS related central nervous system involvement. J Clin Lab Immunol. 1992;38(4):175-86. PMID: 11270518

30– Foppa CU, Bini T, Gregis G, Lazzarin A, Esposito R, Moroni M A retrospective study of primary and maintenance therapy of toxoplasmic encephalitis with oral clindamycin and pyrimethamine. Eur J Clin Microbiol Infect Dis. 1991 Mar;10(3):187-9. IF (1991) 2.259;  PMID: 2060526  ISSN: 0934-9723 (Print), 1435-4373 (Online)

29- Esposito R, Castagna A, Uberti Foppa C. Maintenance therapy of oropharyngeal

candidiasis in HIV-infected patients with fluconazole. AIDS. 1990

Oct;4(10):1033-4. PubMed PMID: 2261119.  IF (1990) 4.407; ISSN: 0269-9370 (Print), 1473-5571 (Electronic)


28-  Rezza G, Lazzarin A, Uberti-Foppa C, Tumbarello M, Menniti-Ippolito F,

Pezzotti P, Titti F, Verani P. Risk behaviour and HTLV-1 seropositivity in

injecting drug users. Br J Addict. 1990 May;85(5):686-7. PubMed PMID: 2354287.


27-  Esposito R, Uberti Foppa C, Cernuschi M. Treatment of invasive fungal

infections in immunocompromised patients with fluconazole. J Chemother. 1989

Jul;1(4 Suppl):925-6. PubMed PMID: 16312707.  IF (2015/2016) 1.604;  ISSN: 1120-009X (Print), 1973-9478 (Online)


26- Esposito R, Foppa CU, Antinori S. Fluconazole for cryptococcal meningitis. Ann Intern Med. 1989 Jan 15;110(2):170. No abstract available. PMID: 2535777 IF (2015/2016) 16.440; ISSN: 0003-4819 (Print), 1539-3704 (Electronic)


25- Esposito R, Uberti Foppa C. Nosography and therapy of opportunistic

infections of the central nervous system in AIDS patients. J Chemother. 1989

Jul;1(4 Suppl):923-4. PubMed PMID: 16312706. .  IF (2015/2016) 1.604;  ISSN: 1120-009X (Print), 1973-9478 (Online).


24- d’Arminio Monforte A, Novati R, Marchisio P, Zanchetta N, Uberti-Foppa C,

Tornaghi R, Massironi E, Lazzarin A, Principi N. Early diagnosis of HIV infection

in infants. AIDS. 1989 Jun;3(6):391-5. PubMed PMID: 2502154. IF (2015/2016) 4.407; ISSN: 0269-9370 (Print), 1473-5571 (Electronic)


23- Vago L, Antonacci MC, Cristina S, Parravicini C, Lazzarin A, Moroni M, Negri

C, Uberti-Foppa C, Musicco M, Costanzi G. Morphogenesis, evolution and prognostic

significance of lymphatic tissue lesions in HIV infection. Appl Pathol.

1989;7(5):298-309. PubMed PMID: 2635617.


22- Galli M, Lazzarin A, Saracco A, Balotta C, Castagna A, Negri C, Ridolfo AL,

Uberti-Foppa C, Corbellino M, Moroni M. Clinical and immunological aspects of HIV

infection in drug addicts. Clin Immunol Immunopathol. 1989 Jan;50(1 Pt

2):S166-76. PubMed PMID: 2562942.


21- Bedarida G, Crocchiolo P, Cambié G, D’Agostino F, Uberti Foppa C, Berto E,

Grisi ME, Arcidiacono I, Ronsivalle MG, Pasquali M, et al. HIV-IgM serology.

Infection. 1988 Sep-Oct;16(5):301-2. PubMed PMID: 3215691.  IF (2015/2016) 2.618;  ISSN: 0300-8126 (Print), 1439-0973 (Online)

20- Franzetti F, Cavalli G, Foppa CU, Amprimo MC, Gaido P, Lazzarin A.Raised serum beta 2 microglobulin levels in different stages of human immunodeficiency virus infection. J Clin Lab Immunol. 1988 Nov;27(3):133-7. Review. PMID: 3073225

19- Tagliabue A, Nencioni L, Mantovani A, Lazzarin A, Villa L, Romano M, Rossini S, Foppa CU, Fanetti G, Masello LC, et al Impairment of in vitro natural antibacterial activity in HIV-infected patients. J Immunol. 1988 Oct 15;141(8):2607-11. PMID: 3262664. IF (2015/2016) 4.922;  ISSN: 0022-1767 (Print), 1550-6606 (Online)

18- Alessi E, Cusini M, Zerboni R, Cavicchini S, Uberti-Foppa C, Galli M, Moroni

  1. Unusual varicella zoster virus infection in patients with the acquired

immunodeficiency syndrome. Arch Dermatol. 1988 Jul;124(7):1011-3. PubMed PMID:

  1. IF (2015/2016) 4.789; ISSN: 0003-987X (Print), 0096-5359 (Online)


17- Scorza Smeraldi R, Fabio G, Lazzarin A, Eisera N, Uberti Foppa C, Moroni M,

Zanussi C. HLA-associated susceptibility to AIDS: HLA B35 is a major risk factor

for Italian HIV-infected intravenous drug addicts. Hum Immunol. 1988

Jun;22(2):73-9. PubMed PMID: 3262099. IF (2015/2016) 2.138;  ISSN: 0198-8859


16-  Lazzarin A, Uberti Foppa C, Crocchiolo P, Verani P, Varnier O, Salvi D. Risk

of HIV-related diseases in heterosexuals importing infection from Zaire. Eur J

Epidemiol. 1988 Mar;4(1):131-2. PubMed PMID: 3356231. IF (2015/2016) 5.339;   ISSN: 0393-2990 (Print), 1573-7284 (Online)


15-  Titti F, Lazzarin A, Costigliola P, Oliva C, Nicoletti L, Negri C, Ricchi E,

Donati G, Uberti-Foppa C, Re MC, et al. Human immunodeficiency virus (HIV)

seropositivity in intravenous (i.v.) drug abusers in three cities of Italy:

possible natural history of HIV infection in i.v. drug addicts in Italy. J Med

Virol. 1987 Nov;23(3):241-8. PubMed PMID: 3430144. IF (2015/2016) 2.347;  ISSN: 0146-6615 (Print), 1096-9071 (Online)

14- Procaccia S, Lazzarin A, Colucci A, Gasparini A, Forcellini P, Lanzanova D, Foppa CU, Novati R, Zanussi C IgM, IgG and IgA rheumatoid factors and circulating immune complexes in patients with AIDS and AIDS-related complex with serological abnormalities. Clin Exp Immunol. 1987 Feb;67(2):236-44. PMID: 3608224. IF (2015/2016) 3.037;   ISSN: 0009-9104 (Print), 1365-2249 (Online)

13-  Lazzarin A, Uberti Foppa C, Negri C, Orlando G, Re T, Moroni M.

Epidemiological aspects of human immunodeficiency virus infection in Milan.

Chemioterapia. 1987 Jun;6(2 Suppl):632-3. PubMed PMID: 3509510.


12-  Uberti Foppa C, Zanchetta N, Nardi G, Re T, Orlando G, Cinque P, Lazzarin A.

Risk of HIV infection in recipients of blood and blood products. Chemioterapia.

1987 Jun;6(2 Suppl):633-4. PubMed PMID: 3334654.


11- Uberti Foppa C, Orando G, Lazzarin A, Zanchetta N, Piero Nardi G, Bedarida G.

Risk of human immunodeficiency virus infection in multiple transfused patients.

Transfusion. 1987 Mar-Apr;27(2):217. PubMed PMID: 3824486. IF (2015/2016) 3.225; ISSN: 0041-1132 (Print), 1537-2995 (Online)



10- Barcellini W, Meroni PL, Frasca D, Sguotti C, Borghi MO, Uberti-Foppa C,

Buzzetti P, Lazzarin A, Doria G, Moroni M, et al. Effect of subcutaneous

thymopentin treatment in drug addicts with persistent generalized

lymphadenopathy. Clin Exp Immunol. 1987 Mar;67(3):537-43. PubMed PMID: 3301099;

PubMed Central PMCID: PMC1542610. IF (2015/2016) 3.037;  ISSN: 0009-9104 (Print), 1365-2249 (Online)


9- Uberti Foppa C, Franzetti F, Negri C, Novati R, Cinque P, Privitera G,

Parente F, Crocchiolo P, Lazzarin A. Role of PMN’s candidicidal activity in the

pathogenesis of AIDS-related systemic candidiases. Boll Ist Sieroter Milan.

1987;66(6):471-8. PubMed PMID: 3502581.


8- Lazzarin A, Crocchiolo P, Galli M, Uberti Foppa C, Caredda F, Re T, Moroni M.

Milan as possible starting point of LAV/HTLV III epidemic among Italian drug

addicts. Boll Ist Sieroter Milan. 1987;66(1):9-13. PubMed PMID: 3304347.


7- Lazzarin A, Barcellini W, Uberti Foppa C, Borghi MO, Franzetti R, Cinque P,

Moroni M. Experiences with immunomodulant agents in HIV infections. Acta

Haematol. 1987;78 Suppl 1:84-90. PubMed PMID: 3124453. IF (2015/2016) 1.116;   ISSN: 0001-5792 (Print), 1421-9662 (Online)


6- Lazzarin A, Uberti Foppa C, Galli M, Mantovani A, Poli G, Franzetti F, Nóvati

  1. Impairment of polymorphonuclear leucocyte function in patients with acquired

immunodeficiency syndrome and with lymphadenopathy syndrome. Clin Exp Immunol.1986 Jul;65(1):105-11. PubMed PMID: 3791696; PubMed Central PMCID: PMC1542272.

IF (2015/2016) 3.037;   ISSN: 0009-9104 (Print), 1365-2249 (Online)


5- Lazzarin A, Luerti M, Capsoni F, Galli M, Uberti-Foppa C, Zavattini G,

Corbella E. A study of cellular immunity in newborns after prevention of

respiratory distress syndrome (RDS). Int J Tissue React. 1986;8(2):157-65. PubMed

PMID: 3700005.


4- Lazzarin A, Orlando G, Privitera G, Crocchiolo P, Esposito R, Uberti Foppa C,

Castagna A, Irato L, Moroni M. Clinical and epidemiological aspects of the first

50 cases of AIDS in Milan. Boll Ist Sieroter Milan. 1986;65(6):481-6. PubMed

PMID: 3580141.


3- Lazzarin A, Uberti-Foppa C, Galli M, Crocchiolo P, Moroni M. Pulmonary

candidiasis in a heroin addict: some remarks on its aetiology and pathogenesis.

Br J Addict. 1985 Mar;80(1):103-4. PubMed PMID: 3856443.


2- Lazzarin A, Mella L, Trombini M, Uberti-Foppa C, Franzetti F, Mazzoni G,

Galli M. Immunological status in heroin addicts: effects of methadone maintenance

treatment. Drug Alcohol Depend. 1984 Mar;13(2):117-23. PubMed PMID: 6609805.

IF (2015/2016) 3.423;    ISSN: 0376-8716.


1- Lazzarin A, Luerti M, Uberti-Foppa C, Zavattini G, Rossi A, Tornaghi R.

Polymorphonuclear leucocytes functions from premature infants after prevention of

respiratory distress syndrome with betamethasone and ambroxol. Biol Res Pregnancy

Perinatol. 1984;5(3):130-4. PubMed PMID: 6478010.




12-C. Uberti-Foppa, G.Gaiera, R.Novati. Infezioni Sistemiche. In: Claudio Rugarli. Medicina Interna Sistematica. VII a ed. Masson; 2015, p 2021-2067. ISBN: 9788821431098

11-A.Castagna, R.Novati, G.Tambussi, C. Uberti-Foppa. Infezioni in Situazioni Particolari. In: Claudio Rugarli. Medicina Interna Sistematica. VII a ed. Masson; 2089-2116. ISBN: 9788821431098

10-Esposito R., Uberti-Foppa C. Infezioni del sistema nervoso. In: Mauro Moroni, Roberto Esposito, Spinello Antinori.  Malattie Infettive.  VIII a ed. Masson;  2014, p 667-765. ISBN: 9788821439728

9-G.Gaiera, R.Novati, C. Uberti-Foppa. Infezioni sistemiche. In: Claudio Rugarli. Medicina Interna Sistematica. VI a ed. Masson; 2010, p 1891-1956. ISBN: 9788821431098

8-A.Castagna,  R.Novati, C. Uberti-Foppa. Infezioni in situazioni particolari. In: Claudio Rugarli. Medicina Interna Sistematica. VI Ia ed. Masson; 2010, p 1973-1993. ISBN: 9788821431098

7-Esposito R., Uberti-Foppa C. Infezioni del sistema nervoso. In: Mauro Moroni, Roberto Esposito.  Malattie Infettive. VII a ed. Masson;  2008. ISBN: 9788821439728

6-Caterina Uberti-Foppa. Febbre di origine sconosciuta. In: Lazzarin A, Andreoni M,  Angarano G, Carosi G, Di Perri G, Sagnelli E. Malattie Infettive. Casa Editrice Ambrosiana; 2008, p 683-690. Isbn 978-8808-18416-0

5-Lazzarin A, Uberti-Foppa C .Patologia infettiva in gravidanza.  In Ferrari GF, Frigerio LG.Manuale di Ginecologia e Ostetricia. Mc Graw Hill; 2004, p 401-413. ISBN: 9788838639708

4-Esposito R., Uberti-Foppa C. Infezioni del sistema nervoso. In: Mauro Moroni, Roberto Esposito.  Malattie Infettive. VI a ed. Masson;  2003. ISBN: 9788821439728

3-R.Novati, C. Uberti-Foppa, G Gaiera. Le infezioni sistemiche. In: Claudio Rugarli. Medicina Interna Sistematica. IV a ed. Masson; 2000, p 1473-1534. ISBN: 9788821431098

2-C. Uberti-Foppa. Patologia Infettiva dell’apparato respiratorio. In: Claudio Rugarli. Medicina Interna Sistematica. IV a ed. Masson; 2000, p 1395-1405. ISBN: 9788821431098

1-Esposito R., Uberti-Foppa C. Infezioni del sistema nervoso. In: Mauro Moroni, Roberto Esposito.  Malattie Infettive. V a ed. Masson;  1998. ISBN: 9788821439728

Il titolare del presente curriculum vitae, pubblicato online sul portale www.unisr.it, è garante in via esclusiva della correttezza e della veridicità dei dati e delle informazioni in esso riportate e del loro eventuale e puntuale aggiornamento. Egli è dunque il diretto ed unico responsabile dei contenuti indicati nei propri curricula.